Explore All Access
Check if your research matches the topics covered in Prostate Cancer and Prostatic Diseases?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Prostate Cancer and Prostatic Diseases : Impact Factor & More
eISSN: 1476-5608pISSN: 1365-7852
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Prostate Cancer and Prostatic Diseases Key Metrics
CiteScore 
7.8
H-Index
74
Impact Factor
< 5
SJR
Q1Urology
SNIP
1.72
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months32%
4 to 6 months45%
7 to 9 months20%
Above 9 months3%
Did you find this useful?
Topics Covered on Prostate Cancer and Prostatic Diseases
Prostate cancer
Androgen deprivation therapy
Overall survival
Family history
Odds ratio
Resistance training
Androgen
Androgen receptor
Quality of life
Prostatectomy
Prostate biopsy
Enzalutamide
Prostate-specific antigen
Definitive radiotherapy
Germline
Erectile dysfunction
Cryotherapy
Clinical significance
Body mass index
Systematic review
Prostate Cancer and Prostatic Diseases Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1997 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Prostate Cancer and Prostatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Prostate Cancer and Prostatic Diseases
Evaluation of the safety and efficacy of stereotactic body radiotherapy for radio-recurrent prostate cancer: a systematic review and meta-analysis.
- 20 Dec 2024
- Prostate cancer and prostatic diseases
Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS).
- 20 Dec 2024
- Prostate cancer and prostatic diseases
Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective single-center study.
- 18 Dec 2024
- Prostate cancer and prostatic diseases
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison.
- 7 Dec 2024
- Prostate cancer and prostatic diseases
Screening for homologous recombination genes.
- 6 Dec 2024
- Prostate cancer and prostatic diseases
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.
- 5 Dec 2024
- Prostate cancer and prostatic diseases
Evaluation of the safety and efficacy of stereotactic body radiotherapy for radio-recurrent prostate cancer: a systematic review and meta-analysis.
- 20 Dec 2024
- Prostate cancer and prostatic diseases
Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS).
- 20 Dec 2024
- Prostate cancer and prostatic diseases
Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective single-center study.
- 18 Dec 2024
- Prostate cancer and prostatic diseases
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison.
- 7 Dec 2024
- Prostate cancer and prostatic diseases
Screening for homologous recombination genes.
- 6 Dec 2024
- Prostate cancer and prostatic diseases
Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer.
- 5 Dec 2024
- Prostate cancer and prostatic diseases
Compare Similar Journals with Prostate Cancer and Prostatic Diseases
Select Journals to Compare with Prostate Cancer and Prostatic Diseases
Total journals - 7
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
European Urology Supplements
Publisher: Elsevier
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
BJU International
Publisher: WILEY
Annals of Oncology
Publisher: ELSEVIER
Clinical Genitourinary Cancer
Publisher: CIG MEDIA GROUP, LP
0 Journals Selected to compare with
Prostate Cancer and Prostatic Diseases
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Prostate Cancer and Prostatic Diseases
How long has Prostate Cancer and Prostatic Diseases been actively publishing? 
Prostate Cancer and Prostatic Diseases has been in operation since 1997 till date.
What is the publishing frequency of Prostate Cancer and Prostatic Diseases?
Prostate Cancer and Prostatic Diseases published with a Quarterly frequency.
How many articles did Prostate Cancer and Prostatic Diseases publish last year?
In 2024, Prostate Cancer and Prostatic Diseases publsihed 154 articles.
What is the eISSN & pISSN for Prostate Cancer and Prostatic Diseases?
For Prostate Cancer and Prostatic Diseases, eISSN is 1476-5608 and pISSN is 1365-7852.
What is Citescore for Prostate Cancer and Prostatic Diseases?
Citescore for Prostate Cancer and Prostatic Diseases is 7.8.
What is the H Index for Prostate Cancer and Prostatic Diseases ?
H Index for Prostate Cancer and Prostatic Diseases is 74.
What is SNIP score for Prostate Cancer and Prostatic Diseases?
SNIP score for Prostate Cancer and Prostatic Diseases is 1.72.
What is the SJR for Prostate Cancer and Prostatic Diseases?
SJR for Prostate Cancer and Prostatic Diseases is Q1.
Who is the publisher of Prostate Cancer and Prostatic Diseases?
SPRINGERNATURE is the publisher of Prostate Cancer and Prostatic Diseases.
